COMMUNIQUÉS West-GlobeNewswire

-
Indus Holdings, Inc. Honored at Monterey County Business Council Economic Vitality Awards Gala
02/07/2019 -
Valneva Submits Delisting Application to the Vienna Stock Exchange
02/07/2019 -
Valneva dépose une demande de radiation de ses actions ordinaires auprès de la bourse de Vienne
02/07/2019 -
Thirty-One Gifts Dedicates Summer Months to Supporting Ronald McDonald House Charities
02/07/2019 -
HIV Eliminated from the Genomes of Living Animals; Excision BioTherapeutics Advancing the Innovation to Clinical Development
02/07/2019 -
Seelos Therapeutics Receives Notice of Allowance for a US Patent for SLS-005 in New Indication of Friedreich Ataxia
02/07/2019 -
Fagron NV: Waterland and Baltisse announce private placement of shares in Fagron
02/07/2019 -
Ludlow Research Initiates Coverage on BioHemp International (BKIT) Based on CBD Distribution Business Model And Assigns A Short Term 'Speculative' Price Target Per Share of $2.50 -$3.50
02/07/2019 -
Generex Engages Donohoe Advisory to Assist with Uplisting
02/07/2019 -
Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance
02/07/2019 -
Surya Psychiatric Clinic Brings Revolutionary FDA-Cleared Mental Health Technology for Major Depressive Disorder (MDD) to Patients in Arizona
02/07/2019 -
Vaccex, Inc. Introductory Press Release
02/07/2019 -
Medtronic Announces Closing of Public Offering of €5 Billion of Senior Notes
02/07/2019 -
Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery
02/07/2019 -
Humanigen Secures Exclusive Worldwide License to Gene-Editing Technology from Mayo Clinic to Improve CAR-T
02/07/2019 -
Agritek Holdings, Inc. Announces Letter of Intent to Acquire Colorado Manufacturing License and Established Vape Brand as New State Legislation Allows Public Company Investment and Acquisitions
02/07/2019 -
World Chocolate Day Dilemma Solved With Umbrellux DAO
02/07/2019 -
Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study
02/07/2019 -
TRACON Pharmaceuticals Provides Update on Phase 1/2 Trial of TRC253 in Patients with Metastatic Castrate Resistant Prostate Cancer
02/07/2019
Pages